PF-AtlasКлинические испытания › NCT06164470

Impact of Support Groups for Patients With Non-Cystic Fibrosis Bronchiectasis

Support Group · Не указано

ID реестра
NCT06164470
Фаза
Не указано
Статус
Завершено
Препарат / вмешательство
Support Group
Спонсор
University of California, San Francisco
Начало
2024-04-01
Набор участников
42
Центры
1

Об исследовании

BronchConnect is a prospective trial to investigate the impact of support groups on health care related quality of life in those with noncystic fibrosis bronchiectasis (NCFBE). It has been well demonstrated that participation in patient support groups improves quality of life in those who suffer from interstitial lung disease and chronic obstructive pulmonary disease, but the impact is largely unknown for those who live with NCFBE, a chronic lung disease with rising prevalence with no targeted FDA-approved therapy. NCFBE causes chronic cough, dyspnea, recurrent infections, and leads to anxiety and uncertainty. This study seeks to evaluate the impact of a virtual patient support group for patients with NCFBE through questionnaires to assess change of quality of life and anxiety, and exacerbation rates through clinical assessment.

Открыть NCT06164470 на ClinicalTrials.gov →

Связанные материалы

Медицинская оговорка. Эта страница обобщает публичные данные исследования NCT06164470 только для информации. Это не медицинская рекомендация, не одобрение и не предложение участия. Проверяйте детали на ClinicalTrials.gov и у квалифицированного врача.